Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program-Reference-Cited by-同舟云学术

Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program

Published:2022-11-07 Issue:2 Volume:16 Page:95-103
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Hudesman David P.^ORCID,Torres Joana^ORCID,Salese Leonardo^ORCID,Woolcott John C.^ORCID,Mundayat Rajiv^ORCID,Su Chinyu^ORCID,Mosli Mahmoud H.^ORCID,Allegretti Jessica R.^ORCID

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

General Engineering

Link

https://link.springer.com/content/pdf/10.1007/s40271-022-00603-w.pdf

Reference26 articles.

1. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative colitis. Lancet. 2017;389(10080):1756–70. https://doi.org/10.1016/S0140-6736(16)32126-2.

2. Colombel JF, Keir ME, Scherl A, Zhao R, de Hertogh G, Faubion WA, et al. Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC. Gut. 2017;66(12):2063–8. https://doi.org/10.1136/gutjnl-2016-312307.

3. de Jong MJ, Huibregtse R, Masclee AAM, Jonkers DMAE, Pierik MJ. Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review. Clin Gastroenterol Hepatol. 2018;16(5):648-63.e3. https://doi.org/10.1016/j.cgh.2017.10.019.

4. Dulai PS, Singh S, Jairath V, Ma C, Narula N, Casteele NV, et al. Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis. Aliment Pharmacol Ther. 2020;51(4):435–45. https://doi.org/10.1111/apt.15577.

5. Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570–83. https://doi.org/10.1053/j.gastro.2020.12.031.